10.09.24 -- Who Handles Maintenance At Your CDMO? You Should Know

Generic drug manufacturers must carefully consider the decision to offshore or nearshore API sourcing. It's not only about managing costs but also about ensuring a stable and reliable supply.

Our panelists describe how the landscape of today’s CDMOs continues to “shift,” what that means, and how to select and form solid partnerships within the changes.

Accurately setting the lower punch ejection height in your tablet press is crucial to the ejection process. Explore how to avoid poorly positioning your punch.

If you’re launching an international clinical trial, consider the noteworthy benefits of partnering with an in-country depot, including increased efficiency, reduced costs, and reliable access to raw materials.

See how PBPK models combined with custom and off-the-shelf in vitro tools and solubility enhancement expertise can reduce the need for drug product reformulation or repeated preclinical or clinical studies.

Examine several important factors needed to effectively support oral solid dosage therapeutic manufacturing and overcome the complexities involved.

The dynamic pharmaceutical landscape demands agility and strategic foresight. Uncover how leveraging a key partnership helped to overcome a looming patent expiry for a second-generation acne medication.

Join the next Outsourced Pharma Live as our panel explores the critical considerations and best practices for selecting and managing CDMOs in the development of novel therapies, including advanced therapy medicinal products like cell and gene therapies. Industry experts will share insights on evaluating CDMO capabilities, ensuring quality and compliance, and fostering effective partnerships to accelerate innovation while mitigating risks.

Pinpoint impurities and conduct confirmatory testing under cGMP with the help of an expert team utilizing cutting-edge mass spectrometry technology to boost your drug product development.

As orally inhaled drug delivery grows to encompass novel therapies and diverse molecule sizes, CDMOs are rising to meet the demand for specialized knowledge and scalable manufacturing capabilities.

The BE3 Flex is a versatile, mid-speed blister packaging machine, designed for high-quality, tool-free format changeovers, accommodating diverse pharmaceutical applications with maximum efficiency.